PES Pathogens in Severe Community-Acquired Pneumonia

Area of Science:

• Infectious Diseases
• Pulmonology
• Critical Care Medicine

Background:

• Community-acquired pneumonia (CAP) poses a significant global health burden.
• Severe CAP often leads to serious complications such as sepsis, septic shock, ARDS, and cardiac events, increasing ICU admissions and mortality.
• While Streptococcus pneumoniae is the most common cause, other pathogens contribute to CAP cases.

Purpose of the Study:

• To highlight the importance of recognizing risk factors for specific challenging pathogens in CAP.
• To emphasize the need for tailored antibiotic therapy for non-typical CAP pathogens.
• To improve clinical outcomes for patients with severe CAP.

Main Methods:

• Literature review on CAP epidemiology and causative agents.
• Analysis of common and emerging pathogens in CAP.
• Discussion of clinical implications for antibiotic selection.

Main Results:

• Streptococcus pneumoniae is the leading cause of CAP.
• Approximately 6% of CAP cases are caused by PES pathogens: Pseudomonas aeruginosa, extended-spectrum β-lactamase Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus.
• Pseudomonas aeruginosa and MRSA are frequently reported and necessitate different treatment strategies than typical CAP pathogens.

Conclusions:

• Recognizing risk factors for PES pathogens is essential for effective CAP management.
• Timely identification and appropriate antibiotic selection are critical for reducing CAP-related morbidity and mortality.
• Further research into risk stratification and targeted therapies for resistant pathogens in CAP is warranted.